
Articles
-
1 week ago |
genengnews.com | Corinna Singleman |Alex Philippidis |Uduak Grace Thomas |Fay Y. Lin
Credit: Just_Super / iStock / Getty Images Plus BIO 2025 is off and running. GEN editors discuss the size and scope of the bustling conference hall and share excitement about the week’s talks and panels. News from BIO includes the announcement of Lilly’s acquisition of Verve Therapeutics. Editors discuss the implications of industry-backed therapeutics amid cautious investors and public sentiment.
-
1 week ago |
genengnews.com | Uduak Grace Thomas
A view of some of the exhibitors in attendance at BIO 2025 [Uduak Thomas] At this year’s BIO International Convention, held June 16–19 in Boston, MA, two companies, 64x Bio and Fauna Bio, introduced new products aimed at improving therapy delivery and identifying novel drug targets for a range of human diseases, respectively. For its part, 64x Bio launched AAV Apex suite, a product designed to address bottlenecks in gene therapy manufacturing.
-
2 weeks ago |
genengnews.com | Uduak Grace Thomas
Home Topics OMICs Proteomics Partnerships Move Multiomics from Theory to Practice Credit: Thom Leach / Science Photo Library David PeoplesCFO, CBOUltima GenomicsMultiomics is in vogue and several sequencing companies have taken notice.
-
2 weeks ago |
genengnews.com | Uduak Grace Thomas
Credit: Alllex Using single-nuclei RNA sequencing (snRNA-seq), scientists from Mass General Brigham, SUNY Upstate Medical University, and elsewhere have identified specific brain cell types in the hippocampus that respond best to physical exercise in mouse models of Alzheimer’s disease. The findings help to elucidate the connection between exercise and brain health, and offer fresh insights into potential treatment strategies for people living with Alzheimer’s.
-
2 weeks ago |
genengnews.com | Uduak Grace Thomas
Source: selvanegra / Getty Images After studying 140,000 versions of the Aβ42 peptide, scientists identified some of the earliest molecular interactions that drive the formation of harmful amyloid protein aggregates found in Alzheimer’s disease cases.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →